ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
-17.28%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$2.96B
AUM Growth
+$2.96B
(-13%)
Cap. Flow
+$439M
Cap. Flow
% of AUM
14.82%
Top 10 Holdings %
Top 10 Hldgs %
65.67%
Holding
42
New
12
Increased
9
Reduced
9
Closed
–
Top Buys
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$77.3M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$61.8M |
| 3 |
PTC Therapeutics
PTCT
|
$53.5M |
| 4 |
Relmada Therapeutics
RLMD
|
$39.2M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$34.7M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$17.1M |
| 2 |
Ascendis Pharma
ASND
|
$8.78M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$5.92M |
| 4 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$4.92M |
| 5 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$4.29M |
Sector Composition
| 1 | Healthcare | 87.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $330M | 11.15% | 24,500,000 | – | – |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $316M | 10.67% | 4,112,700 +262,500 | +7% | +$20.2M |
|
3
Iovance Biotherapeutics
IOVA
$807M
| $270M | 9.1% | 9,010,413 +184,374 | +2% | +$5.52M |
|
|
4
Ascendis Pharma
ASND
$11.8B
| $201M | 6.79% | 1,787,000 -78,000 | -4% | -$8.78M |
|
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $163M | 5.5% | 1,930,000 -70,000 | -4% | -$5.92M |
|
|
6
Sarepta Therapeutics
SRPT
$1.78B
| $155M | 5.23% | 1,585,000 -175,000 | -10% | -$17.1M |
|
|
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $136M | 4.57% | 4,575,000 +575,000 | +14% | +$17M |
|
8
Karyopharm Therapeutics
KPTI
$61.7M
| $134M | 4.54% | 7,000,000 +1,100,000 | +19% | +$21.1M |
|
9
argenx
ARGX
$43.6B
| $123M | 4.16% | 936,500 | – | – |
|
|
CNST
10
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $115M | 3.87% | 3,650,000 | – | – |
|
11
Amicus Therapeutics
FOLD
$2.34B
| $101M | 3.42% | 10,950,000 -250,000 | -2% | -$2.31M |
|
|
DCPH
12
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $82.3M | 2.78% | 2,000,000 +1,500,000 | +300% | +$61.8M |
|
13
uniQure
QURE
$896M
| $78.3M | 2.64% | 1,650,000 -50,000 | -3% | -$2.37M |
|
|
XLRN
14
DELISTED
Acceleron Pharma Inc.
XLRN
| $77.3M | 2.61% | +860,000 | New | +$77.3M |
|
15
Adverum Biotechnologies
ADVM
$64.6M
| $69.9M | 2.36% | 7,150,000 +1,900,000 | +36% | +$18.6M |
|
|
ZGNX
16
DELISTED
Zogenix, Inc.
ZGNX
| $69.2M | 2.34% | 2,800,000 +800,000 | +40% | +$19.8M |
|
|
MYOK
17
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $67.3M | 2.27% | 1,435,000 -105,000 | -7% | -$4.92M |
|
|
18
PTC Therapeutics
PTCT
$3.92B
| $53.5M | 1.81% | +1,200,000 | New | +$53.5M |
|
|
19
Relmada Therapeutics
RLMD
$37.2M
| $39.2M | 1.32% | +1,150,000 | New | +$39.2M |
|
|
ATNX
20
DELISTED
Athenex, Inc. Common Stock
ATNX
| $37.7M | 1.27% | 4,875,000 -386,437 | -7% | -$2.99M |
|
|
AVDL
21
Avadel Pharmaceuticals
AVDL
$1.43B
| $34.7M | 1.17% | +4,365,655 | New | +$34.7M |
|
22
Xenon Pharmaceuticals
XENE
$2.98B
| $31.4M | 1.06% | 2,772,000 +372,000 | +16% | +$4.22M |
|
|
TCDA
23
DELISTED
Tricida, Inc. Common Stock
TCDA
| $30M | 1.01% | 1,365,000 -195,000 | -13% | -$4.29M |
|
|
SAGE
24
DELISTED
Sage Therapeutics
SAGE
| $28.7M | 0.97% | +1,000,000 | New | +$28.7M |
|
25
Cue Biopharma
CUE
$60M
| $26.5M | 0.9% | 1,870,000 | – | – |
|